Skip to content
LogiclyLogicly

Free for 14 days. No card to start.

Get started free

E26 Hyperaldosteronism

E26 is the ICD-10-CM code family for Hyperaldosteronism: 7 codes, 6 of which can lead a home health claim.

Codes in family

7

Can lead a claim

6

Cannot lead a claim

1

What CMS assigns to E26

6 of the 7 codes group to MMTA - Endocrine; 1 is assigned no clinical group. None of the 7 is assigned a comorbidity subgroup. 6 of the 7 can lead a claim.

Every code in E26

Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.

CodeDescriptionPrimary positionClinical groupComorbidity subgroup
E26.0 Primary hyperaldosteronism
E26.01Conn's syndromeCan lead a claimINone
E26.02Glucocorticoid-remediable aldosteronismCan lead a claimINone
E26.09Other primary hyperaldosteronismCan lead a claimINone
E26.1Secondary hyperaldosteronismCan lead a claimINone
E26.8 Other hyperaldosteronism
E26.81Bartter's syndromeCan lead a claimINone
E26.89Other hyperaldosteronismCan lead a claimINone
E26.9Hyperaldosteronism, unspecifiedCannot lead a claimPrincipal diagnosis not assigned to a clinical groupNoneNone

Sources: CMS HH PPS Grouper Software (opens in a new tab) v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 (opens in a new tab) code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.